"Designing Growth Strategies is in our DNA"
The global drug delivery systems market size was USD 26.08 billion in 2019 and is projected to reach USD 45.20 billion by 2027, exhibiting a CAGR of 6.8% during the forecast period.
Controlled administration of medication is aided by advancements in drug delivery systems. These systems control the rate at which a drug is released. In the past few decades, the practice of drug delivery has changed tremendously, and even greater changes are expected in the near future. Recent scientific advances by biomedical engineers have focused to understand the functional barriers to effective drug delivery, which includes delivery in the circulatory system and drug movement through cells and tissues. The rising global adoption of these devices is attributable to factors such as introduction of advanced technologies for effectively delivering the drug on the target site, reduction of side effects, and surging demand for new, innovative products. For instance, in January 2019, AstraZeneca collaborated with Aptamer Group to advance a next-generation drug delivery device for the kidneys.
Request a Free sample to learn more about this report.
Increased Focus Towards Drug Delivery Systems with Better Safety and Dosing Outcomes to Fuel the Market
One of the recent market trends is the development and launch of products with features such as increased safety and user friendliness. The shifting focus towards the adoption of advanced technologies has significantly improved operational performances of these devices. Better dosing features also complement drug treatment outcomes and to increase the potential of disease management in home settings.
For Instance, in November 2019, Lupin Limited announced the release of a new connected smart device for metered-dose inhalers called ADHERO. This novel device is specially designed for patients suffering from chronic respiratory diseases to track their Metered Dose Inhaler (MDI) usage and facilitate an improved compliance to therapy.
In addition, the digital aspect of drug delivery is helping patient population by ensuring that the patients get the appropriate therapeutic dose for their diagnosed condition. This, in turn, is fostering the need for novel and smart devices in the market such as wearables.
Higher Focus on Novel Technologies is Paving Way for the Growth of the Market
Rapidly modernizing technologies that involve digitalization have enabled the development of novel discoveries and innovations in the field of these systems. The onset of technologies that facilitate proper dose monitoring and treatment of patients is estimated to further boost the drug delivery systems market growth.
For instance, in January 2020, AptarGroup, Inc. received U.S FDA approval for its innovative Unidose Liquid System, a nasal spray device indicated for the treatment of epilepsy and seizures.
One of the major components estimated to propel medical devices technologies is the recent innovative minimally invasive techniques developed by some of the major players indicated to treat diseases that require longer prognosis. In addition, these technological advancements provide dual benefits of giving patient less pain with better efficacy of treatment. Moreover, the rise in mergers and collaborations among major companies focused to develop integrated medical solutions is projected to boost the market, cumulatively providing a larger array of preferences to the consumers.
Increasing Prevalence of Chronic Diseases to Augment Market Growth
The increasing prevalence of diseases such as diabetes, COPD, and asthma combined with rising ageing population is anticipated to drive the market growth. With increasing life expectancy in the developed and developing countries, the demand for at-home convenient drug delivery products has sharply risen. For instance, according to the International Diabetes Federation (IDF), in 2019, approximately 463 million individuals suffered from diabetes. Additionally, around 1.1 million children suffered from type 1 diabetes. The report also states that 1 out of 5 adults that have diabetes are 65 years and older. According to the Global Burden of Disease Study, the prevalence of COPD globally was estimated to be 251 million in 2016.
Digitalization in the healthcare sector has lead to innovations in drug delivery systems. Manufacturers are now focused towards innovating devices that provide facilities such as digital monitoring of doses and compatibility with digital applications, among others. Such developments could positively augment the growth of this market.
Frequent Changes In Regulatory Approval Process Of Combination Products Coul Harm The Growth Of The Market
The technologically advanced drug delivery systems are suspected to various regulatory approval process. Since these technologies are upcoming with various innovations, regulatory bodies have enforced active efforts to evaluate the performance and safety of the products. The constant advancement in smart drug delivery systems have also substantially increased the burden on regulatory bodies for the product’s classification and evaluation. For instance, in November 2019, the U.S FDA issued a draft guidance of product development and regulatory approval process of topical and transdermal delivery systems. This could pose a challenge for companies that have significantly advanced in the development process of the product.
The recent product recalls attributed to software malfunctioning of the device have also compelled the regulatory authorities like European Agency and the Food and Drug Administration to impose stringent guideline for the approval of the systems for drug delivery. These predominant factors could limit the growth of market during the forecast years.
To know how our report can help streamline your business, Speak to Analyst
Injectable Segment to Register Remarkable Growth
The report focuses on drug delivery systems market trends covering different product types that include injectable, inhalation devices, transdermal devices, and others. The injectable segment is expected to dominate the market share owing to the system’s capability to deliver drugs to the target site, allowing it to be more localized. Likewise, shifting patient preference from syringe to readymade devices is also expected to boost the segment growth.
The transdermal segment is anticipated to hold the second position in the market owing to technological advancements and advantages provided by transdermal drug delivery systems.
On the other hand, the inhalation and others segment are anticipated to mark significant growth in the forecast period owing to th advancements such as agglomerated vesicle technology, MDI electronic dose counter, particle engineering, and supercritical fluid technology
Conventional Drug Delivery Segment to Dominate Market Share
Based on type, the market has been segmented into conventional and advanced. The conventional segment accounts for the leading share in the market. The large share of this segment is due to the rising incidence of chronic diseases (mainly cancer and diabetes) and cardiovascular diseases (CVD), growing demand for biosimilar products, and low cost of devices and manufacturing. According to the World Health Organization (WHO), around 300 million people worldwide have been diagnosed with asthma. Although advanced devices have been introduced in the market, injectable, pen-injectors, and inhalers are still usually adopted globally.
On the other hand, rising geriatric population, technological advancements, and increasing demand for improved systems are the key factors driving the growth of the advanced segment.
Hospital Pharmacies Segment Held the Highest Market Share
On the basis of distribution channels, the market is divided into hospital pharmacies, retail pharmacies, and others. The hospital pharmacies segment is predicted to account for a dominant share in the market during the forecast period. This is attributed to the growing number of hospitalizations. Furthermore, hospitals provide extensive treatments, quick reimbursements, and insurance policies due to which patients prefer hospital pharmacies .
The retail pharmacies segment is estimated to emerge as the fastest-growing segment during the forecast period. Due to an increasing patient demand, retail pharmacies are likely to invest in products such as, injectables, infusion pumps, inhalers, etc. thus increasing the market values. Moreover, associated benefits such as convenience, discounts, and flexibility is driving the growth of the online channels segment during the forecast period.
North America Drug Delivery Systems Market Size, 2019 (USD Billion)
To get more information on the regional analysis of this market, Request a Free sample
With a market value of USD 10.65 billion in 2019, North America emerged as the leading region and is also anticipated to dominate the market share in the coming years. The rapid growth of the chronic diseases such as diabetes in the U.S., is driven by the increasing awareness and the ongoing R&D in advanced devices, coupled with new product launches are the major factors responsible for North America’s dominance.
Europe accounted for the second-largest market share. Growing incidence of chronic diseases and presence of a large target population base are the factors boosting product demand in the region. This, coupled with the presence of big pharma companies in countries such as Ireland, Italy, Switzerland, and others, is anticipated to fuel the market growth. For Instance, in July 2018, Companion Medical, a leader in the development of advanced device type to improve diabetes care, received FDA approval for the android version of its InPen app, clearing the way for the release of smart pen system for android users. The InPen automatically calculates the insulin doses, and gives out dose reminders.
On the other hand, Asia-Pacific is projected to register a higher CAGR during the forecast period due to the factors such as constant increase in number of asthmatic and allergic rhinitis patients is anticipated to propel the market demand for these systems in Asia Pacific region. Latin America and the Middle East & Africa are anticipated to witness a moderate CAGR during the forecast period owing to the rising lifestyle illness and growing initiatives by the government to enhance the accessibility of drugs are likely to accelerate the usage of conventional products in the region during the forecast period.
BD, Baxter International, Gerresheimer AG, and West Pharmaceutical Services Account for a Dominant Share
The market is dominated by companies such as BD, Baxter International, Inc., Gerresheimer AG, and West Pharmaceutical Services, Inc. Driven by a diversified product portfolio and a wide distribution network, these companies will continue to dominate the market in the coming years. In October 2019, Becton, Dickinson and Company launched the BD Intevia 1mL two-step disposable autoinjector, a robust platform device combining autoinjector and pre-fillable syringe in one integrated system. In addition to establishing a strong distribution network, companies are also emphasizing on acquisitions to possess a diverse range of these systems. For instance, in May 2020, 3M’s Drug Delivery Systems (DDS) business was acquired by Altaris Capital Partners and renamed Kindeva Drug Delivery. The business includes more than 50 years of pharmaceutical development, commercialization, and contract manufacturing services experience across the inhalation, nasal, transdermal, and microneedles domains.Other market players engaged in this market are 3M, Ypsomed, Pfizer, Inc., and Nemera, among others.
An Infographic Representation of Drug Delivery Systems Market
To get information on various segments, share your queries with us
The drug delivery systems market research report includes detailed information on various aspects of the market. Some of them are growth drivers, restraints, competitive landscape, regional analysis, and challenges. It further offers an analytical depiction of the neurovascular devices market trends and estimations to illustrate the forthcoming investment pockets. The market is quantitatively analyzed from 2019 to 2026 to provide the financial competency of the market. The information gathered in the report has been taken from several primary and secondary sources.
Value (USD Billion)
By Device Type
By Distribution Channels
Based on the detailed study conducted by Fortune Business Insights, the market size stood at USD 26.08 billion in 2019.
Fortune Business Insights estimates that the value of the market will reach USD 45.20 billion in 2027.
The market is expected to grow at a CAGR of 6.8% during the forecast period
In 2019, North America accounted for around 40.8% of the global market share and its size was at USD 10.64 billion.
Increasing prevalence of chronic diseases is the key driver for this market
BD, Baxter International, Inc., Gerresheimer AG, and West Pharmaceutical Services, Inc. are the companies that dominated the market in 2019.
Many systems are being developed at present, which are based on various approaches based on advanced technologies and are expected to be launched in the forecast period, which will see a high adoption among patients suffering from chronic disorders.
“We are happy with the professionalism of your in-house research team as well as the quality of your research reports. Looking forward to work together on similar projects”- One of the Leading Food Companies in Germany
“We appreciate the teamwork and efficiency for such an exhaustive and comprehensive report. The data offered to us was exactly what we were looking for. Thank you!”- Intuitive Surgical
“I recommend Fortune Business Insights for their honesty and flexibility. Not only that they were very responsive and dealt with all my questions very quickly but they also responded honestly and flexibly to the detailed requests from us in preparing the research report. We value them as a research company worthy of building long-term relationships.”- Major Food Company in Japan
“Well done Fortune Business Insights! The report covered all the points and was very detailed. Looking forward to work together in the future”- Ziering Medical
“It has been a delightful experience working with you guys. Thank you Fortune Business Insights for your efforts and prompt response”- Major Manufacturer of Precision Machine Parts in India
“I had a great experience working with Fortune Business Insights. The report was very accurate and as per my requirements. Very satisfied with the overall report as it has helped me to build strategies for my business”- Hewlett-Packard
“This is regarding the recent report I bought from Fortune Business insights. Remarkable job and great efforts by your research team. I would also like to thank the back end team for offering a continuous support and stitching together a report that is so comprehensive and exhaustive”- Global Management Consulting Firm
“Please pass on our sincere thanks to the whole team at Fortune Business Insights. This is a very good piece of work and will be very helpful to us going forward. We know where we will be getting business intelligence from in the future.”- UK-based Start-up in the Medical Devices Sector
“Thank you for sending the market report and data. It looks quite comprehensive and the data is exactly what I was looking for. I appreciate the timeliness and responsiveness of you and your team.”- One of the Largest Companies in the Defence Industry